Tadashi Nakamura Selected Research

AA amyloidosis

1/2023	Down-regulated Th17 cells in a patient with familial Mediterranean fever associated with amyloid A amyloidosis in the treatment of canakinumab.
1/2020	Amyloid A amyloidosis in a patient with Caplan's syndrome, with special reference to genetic predisposition.
1/2019	Systemic AA amyloidosis secondary to rheumatoid arthritis may be treatable but is still difficult to manage in daily clinical practice.
7/2014	Abatacept may be effective and safe in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
3/2014	Amyloid A amyloidosis in a Japanese patient with familial Mediterranean fever associated with homozygosity for the pyrin variant M694I/M694I.
11/2012	Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
9/2011	Amyloid A amyloidosis secondary to rheumatoid arthritis: pathophysiology and treatments.
12/2010	Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
1/2008	Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis.
11/2006	HLA-DRB1*04 alleles in Japanese rheumatoid arthritis patients with AA amyloidosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tadashi Nakamura Research Topics

Disease

24	Rheumatoid Arthritis 11/2023 - 12/2003
9	Atherosclerosis 01/2023 - 09/2002
7	Type 2 Diabetes Mellitus (MODY) 01/2023 - 04/2004
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2011
7	Hypertension (High Blood Pressure) 01/2021 - 01/2003
7	Obesity 07/2014 - 09/2003
5	Inflammation (Inflammations) 01/2023 - 01/2008
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2008 - 04/2004
4	Hyperglycemia 01/2022 - 09/2003
4	Insulin Resistance 08/2005 - 09/2002
4	Hypoadiponectinemia 11/2004 - 09/2002
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 09/2002
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020 - 09/2011
3	Necrosis 01/2019 - 03/2007
3	Hypertriglyceridemia 07/2014 - 01/2010
3	Coronary Artery Disease (Coronary Atherosclerosis) 04/2004 - 01/2003
2	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2023 - 01/2012
2	Familial Mediterranean Fever (Periodic Disease) 01/2023 - 03/2014
2	Pancreatitis 01/2022 - 01/2010
2	Diabetes Mellitus 09/2021 - 01/2003
2	Rheumatic Diseases (Rheumatism) 02/2020 - 12/2017
2	Body Weight (Weight, Body) 01/2020 - 08/2010
2	Lung Diseases (Lung Disease) 01/2020 - 01/2016
2	Adult-Onset Still's Disease 12/2018 - 12/2017
2	Synovitis 11/2018 - 09/2005
2	Hyperuricemia 11/2011 - 06/2011
2	Abdominal Obesity 06/2011 - 03/2005
2	Dyslipidemias (Dyslipidemia) 06/2011 - 01/2003
2	Xanthomatosis (Xanthoma) 01/2010 - 08/2005
2	Infections 09/2006 - 07/2002
2	Secondary Hyperparathyroidism 09/2005 - 08/2005
2	Amyloidosis 12/2004 - 12/2003
2	Vomiting 01/2004 - 05/2003
2	Hyperlipoproteinemia Type III (Broad Beta Disease) 06/2003 - 06/2003
1	Idiopathic Pulmonary Fibrosis 11/2023
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022
1	Autonomic Nervous System Diseases (Dysautonomia) 02/2020
1	Autoimmune Diseases (Autoimmune Disease) 02/2020
1	Carotid Artery Diseases 01/2020
1	Caplan Syndrome 01/2020
1	Pneumoconiosis 01/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Tardive Dyskinesia 05/2019
1	Dementia (Dementias) 05/2019
1	Bronchitis 01/2019
1	Myocardial Infarction 01/2019

Drug/Important Bio-Agent (IBA)

20	AdiponectinIBA 01/2021 - 06/2002
12	AA amyloidosisIBA 01/2023 - 12/2003
8	Amyloid (Amyloid Fibrils)IBA 01/2020 - 12/2003
6	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 10/2002
5	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 01/2023 - 10/2017
5	HLA-DRB1 Chains (HLA DRB1)IBA 12/2017 - 11/2006
4	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 10/2017
4	HDL LipoproteinsIBA 01/2021 - 08/2005
4	Biomarkers (Surrogate Marker)IBA 11/2018 - 12/2003
4	Etanercept (Enbrel)FDA Link 11/2012 - 01/2008
3	Monoclonal AntibodiesIBA 01/2023 - 09/2005
3	EnzymesIBA 01/2022 - 01/2013
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 08/2005
3	CholesterolIBA 01/2021 - 03/2005
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016 - 01/2005
3	Insulin (Novolin)FDA Link 06/2012 - 10/2002
2	InflammasomesIBA 01/2023 - 12/2018
2	Sodium-Glucose Transport ProteinsIBA 01/2023 - 01/2020
2	PyrinIBA 01/2023 - 03/2014
2	Colchicine FDA LinkGeneric 01/2023 - 03/2014
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2020
2	Lipase (Acid Lipase)FDA Link 01/2022 - 01/2010
2	SodiumIBA 09/2021 - 10/2017
2	HDL CholesterolIBA 01/2021 - 12/2008
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 04/2004
2	AutoantibodiesIBA 02/2020 - 01/2007
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 12/2004
2	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 09/2015
2	Hemoglobins (Hemoglobin)IBA 09/2013 - 06/2011
2	Peroxidase (Myeloperoxidase)IBA 01/2013 - 01/2007
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2012 - 12/2003
2	EpitopesIBA 01/2012 - 11/2006
2	AdipokinesIBA 01/2011 - 11/2009
2	Lipoproteins (Lipoprotein)IBA 03/2005 - 06/2003
1	NucleotidesIBA 11/2023
1	InterleukinsIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	canakinumab FDA Link 01/2023
1	Pancreatic Elastase (Elastase)IBA 01/2022
1	Amylases FDA Link 01/2022
1	KetonesIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Cholinergic ReceptorsIBA 02/2020
1	LuciferasesIBA 02/2020
1	AntibodiesIBA 02/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	Coal (Coals)IBA 01/2020
1	Domperidone (Domperidon)IBA 05/2019
1	Biological FactorsIBA 01/2019

Therapy/Procedure

4	Therapeutics 01/2019 - 09/2005
2	Glycemic Control 10/2017 - 09/2013
2	Biological Therapy 09/2011 - 12/2010